Introducing "Immunity" your ultimate defense shield
Studies examine whether BPC-157 influences TB-500 stability or transport during simulated gastrointestinal transit and whether co-formulation alters the behavior of either peptide
Jeff Cohen, co-founder of the American Peptide Association, which provides clinical guidance for doctors and organizations, says that the FDA system of evaluating and approving drugs based on expensive, large-scale clinical trials is unrealistic for this industry
Studies in animal models have shown it may help protect and repair the lining of the stomach and intestines, with research exploring its effects on gastric ulcers, inflammatory bowel conditions, and intestinal tissue damage
This is another reason why dangerous, highly-localized injections should be avoided
It is not a licensed medicine, not approved for human consumption, and must not be used in any clinical, therapeutic, veterinary, or diagnostic context outside of properly regulated research frameworks
